Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-hLH vs u-hCG for Ovulation Induction
NCT01735422Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Dec 1999
- Primary completion
- Jul 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lutropin alfa in female infertility (6 arms), sponsored by Merck KGaA. Primary endpoints: Ovulation rate, Ratio of ruptured follicles per follicle with diameter >= 15 mm and 2 more. Started Dec 1999; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT01735422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01735422.